-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Short Interest in Centogene (NASDAQ:CNTG) Drops By 20.1%
Short Interest in Centogene (NASDAQ:CNTG) Drops By 20.1%
Centogene (NASDAQ:CNTG – Get Rating) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 18,700 shares, a decrease of 20.1% from the June 30th total of 23,400 shares. Approximately 0.3% of the company's shares are sold short. Based on an average daily volume of 9,600 shares, the short-interest ratio is currently 1.9 days.
Centogene Stock Performance
NASDAQ CNTG opened at $1.55 on Thursday. The company has a market capitalization of $30.78 million, a price-to-earnings ratio of -0.64 and a beta of -1.18. Centogene has a twelve month low of $1.34 and a twelve month high of $11.61. The stock has a fifty day simple moving average of $2.24 and a 200 day simple moving average of $3.30. The company has a quick ratio of 2.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.67.
Get Centogene alerts:Centogene (NASDAQ:CNTG – Get Rating) last issued its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. The business had revenue of $11.59 million for the quarter. Sell-side analysts expect that Centogene will post -1.72 EPS for the current year.
Institutional Trading of Centogene
An institutional investor recently bought a new position in Centogene stock. DekaBank Deutsche Girozentrale bought a new stake in Centogene (NASDAQ:CNTG – Get Rating) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 16,319 shares of the company's stock, valued at approximately $67,000. DekaBank Deutsche Girozentrale owned 0.08% of Centogene at the end of the most recent reporting period.Analyst Ratings Changes
Separately, SVB Leerink decreased their price objective on Centogene from $10.00 to $6.00 and set an "outperform" rating for the company in a report on Monday, July 18th.
Centogene Company Profile
(Get Rating)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Read More
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
Centogene (NASDAQ:CNTG – Get Rating) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 18,700 shares, a decrease of 20.1% from the June 30th total of 23,400 shares. Approximately 0.3% of the company's shares are sold short. Based on an average daily volume of 9,600 shares, the short-interest ratio is currently 1.9 days.
Centogene(納斯達克：CNTG-GET Rating)是空頭股數7月份大幅下降的目標。截至7月15日，空頭股數共有18,700股，較6月30日的23,400股減少20.1%。該公司約0.3%的股票被賣空。以日均成交量9,600股計算，短息比率目前為1.9天。
Centogene Stock Performance
世紀之交股票表現
NASDAQ CNTG opened at $1.55 on Thursday. The company has a market capitalization of $30.78 million, a price-to-earnings ratio of -0.64 and a beta of -1.18. Centogene has a twelve month low of $1.34 and a twelve month high of $11.61. The stock has a fifty day simple moving average of $2.24 and a 200 day simple moving average of $3.30. The company has a quick ratio of 2.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.67.
新浪納斯達克週四開盤價為1.55美元。該公司市值為3,078萬美元，市盈率為-0.64倍，貝塔係數為-1.18。Centogene的12個月低點為1.34美元，12個月高位為11.61美元。該股的50日簡單移動均線為2.24美元，200日簡單移動均線為3.30美元。該公司的速動比率為2.41，流動比率為2.48，債務權益比率為0.67。
Centogene (NASDAQ:CNTG – Get Rating) last issued its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. The business had revenue of $11.59 million for the quarter. Sell-side analysts expect that Centogene will post -1.72 EPS for the current year.
Centogene(納斯達克：CNTG-GET Rating)上一次發佈季度收益報告是在7月15日(星期五)。該公司公佈了本季度每股收益(0.54美元)。Centogene的淨資產回報率為負134.55%，淨利潤率為負35.35%。該業務本季度的收入為1159萬美元。賣方分析師預計，Centogene本年度每股收益將達到1.72歐元。
Institutional Trading of Centogene
世紀之交的機構交易
Analyst Ratings Changes
分析師評級發生變化
Separately, SVB Leerink decreased their price objective on Centogene from $10.00 to $6.00 and set an "outperform" rating for the company in a report on Monday, July 18th.
另外，SVB Leerink在7月18日週一的一份報告中將Centogene的目標價從10.00美元下調至6.00美元，併為該公司設定了“跑贏大盤”的評級。
Centogene Company Profile
Centogene公司簡介
(Get Rating)
(獲取評級)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Centogene N.V.及其子公司專注於罕見疾病，將現實世界的臨牀和基因或其他數據轉換為可操作的信息，供世界各地的患者、醫生和製藥公司使用。它通過三個部門運作：製藥、診斷和新冠肺炎測試。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
- 免費獲取StockNews.com關於Centogene的研究報告(CNTG)
- 有不同類型的股票可供投資
- 是時候開發Molson Coors了，還是啤酒銷售會變得平淡？
- 星巴克是在向月球進軍嗎？
- PayPal繼續掙扎，競爭加劇
- 你不應該忽視的兩個高收益深度價值
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
接受《世紀英文報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Centogene和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧